Drug-use evaluation programs in short-term-care general hospitals

A. K. Terry, J. R. Draugalis, J Lyle Bootman

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The results of a survey to assess drug-use evaluation (DUE) programs in short-term-care general U.S. hospitals are reported. During February 1992, questionnaires were mailed to pharmacy directors at 491 randomly selected short-term-care general hospitals with 100 or more beds. The questionnaire was designed to collect information on the characteristics of surveyed hospitals and their pharmacies, DUE program characteristics, and the perceptions of pharmacists about the DUE programs. The net response rate was 66.6% (327 usable replies). Pharmacist involvement in DUE program activities was found to be very high, with two thirds of respondents indicating they participated in all five ASHP-recommended activities. Pharmacists rated the effectiveness of current DUE programs as moderate, while the importance of pharmacist participation was perceived to be very high. Pharmacists were members of 97.9% of the respondents' DUE committees, but only 65.5% of the pharmacist members held voting privileges. Pharmacists reported devoting an average of 11.27 hours weekly to DUE-related tasks. Reasons used to select drugs for DUEs, interventions employed, uses of DUE results, and methods of evaluating the effectiveness of DUE programs all varied widely. In short- term-care general hospitals with 100 or more beds, pharmacists assigned to DUE activities were highly involved in DUE committees and programs. The effectiveness of these activities needs to be assessed in more detail.

Original languageEnglish (US)
Pages (from-to)940-944
Number of pages5
JournalAmerican Journal of Hospital Pharmacy
Volume50
Issue number5
StatePublished - 1993
Externally publishedYes

Fingerprint

Drug Evaluation
General Hospitals
Pharmacists
Pharmacies
Politics
Surveys and Questionnaires

Keywords

  • Administration
  • American Society of Hospital Pharmacists
  • Committees
  • Data collection
  • Drug use
  • Guidelines
  • Hospitals
  • Pharmacists, hospital
  • Pharmacy, institutional, hospital

ASJC Scopus subject areas

  • Leadership and Management
  • Pharmaceutical Science

Cite this

Drug-use evaluation programs in short-term-care general hospitals. / Terry, A. K.; Draugalis, J. R.; Bootman, J Lyle.

In: American Journal of Hospital Pharmacy, Vol. 50, No. 5, 1993, p. 940-944.

Research output: Contribution to journalArticle

@article{9a76acf4ba3a45ef9b7de3e379e45e65,
title = "Drug-use evaluation programs in short-term-care general hospitals",
abstract = "The results of a survey to assess drug-use evaluation (DUE) programs in short-term-care general U.S. hospitals are reported. During February 1992, questionnaires were mailed to pharmacy directors at 491 randomly selected short-term-care general hospitals with 100 or more beds. The questionnaire was designed to collect information on the characteristics of surveyed hospitals and their pharmacies, DUE program characteristics, and the perceptions of pharmacists about the DUE programs. The net response rate was 66.6{\%} (327 usable replies). Pharmacist involvement in DUE program activities was found to be very high, with two thirds of respondents indicating they participated in all five ASHP-recommended activities. Pharmacists rated the effectiveness of current DUE programs as moderate, while the importance of pharmacist participation was perceived to be very high. Pharmacists were members of 97.9{\%} of the respondents' DUE committees, but only 65.5{\%} of the pharmacist members held voting privileges. Pharmacists reported devoting an average of 11.27 hours weekly to DUE-related tasks. Reasons used to select drugs for DUEs, interventions employed, uses of DUE results, and methods of evaluating the effectiveness of DUE programs all varied widely. In short- term-care general hospitals with 100 or more beds, pharmacists assigned to DUE activities were highly involved in DUE committees and programs. The effectiveness of these activities needs to be assessed in more detail.",
keywords = "Administration, American Society of Hospital Pharmacists, Committees, Data collection, Drug use, Guidelines, Hospitals, Pharmacists, hospital, Pharmacy, institutional, hospital",
author = "Terry, {A. K.} and Draugalis, {J. R.} and Bootman, {J Lyle}",
year = "1993",
language = "English (US)",
volume = "50",
pages = "940--944",
journal = "American Journal of Health-System Pharmacy",
issn = "1079-2082",
publisher = "American Society of Health-Systems Pharmacy",
number = "5",

}

TY - JOUR

T1 - Drug-use evaluation programs in short-term-care general hospitals

AU - Terry, A. K.

AU - Draugalis, J. R.

AU - Bootman, J Lyle

PY - 1993

Y1 - 1993

N2 - The results of a survey to assess drug-use evaluation (DUE) programs in short-term-care general U.S. hospitals are reported. During February 1992, questionnaires were mailed to pharmacy directors at 491 randomly selected short-term-care general hospitals with 100 or more beds. The questionnaire was designed to collect information on the characteristics of surveyed hospitals and their pharmacies, DUE program characteristics, and the perceptions of pharmacists about the DUE programs. The net response rate was 66.6% (327 usable replies). Pharmacist involvement in DUE program activities was found to be very high, with two thirds of respondents indicating they participated in all five ASHP-recommended activities. Pharmacists rated the effectiveness of current DUE programs as moderate, while the importance of pharmacist participation was perceived to be very high. Pharmacists were members of 97.9% of the respondents' DUE committees, but only 65.5% of the pharmacist members held voting privileges. Pharmacists reported devoting an average of 11.27 hours weekly to DUE-related tasks. Reasons used to select drugs for DUEs, interventions employed, uses of DUE results, and methods of evaluating the effectiveness of DUE programs all varied widely. In short- term-care general hospitals with 100 or more beds, pharmacists assigned to DUE activities were highly involved in DUE committees and programs. The effectiveness of these activities needs to be assessed in more detail.

AB - The results of a survey to assess drug-use evaluation (DUE) programs in short-term-care general U.S. hospitals are reported. During February 1992, questionnaires were mailed to pharmacy directors at 491 randomly selected short-term-care general hospitals with 100 or more beds. The questionnaire was designed to collect information on the characteristics of surveyed hospitals and their pharmacies, DUE program characteristics, and the perceptions of pharmacists about the DUE programs. The net response rate was 66.6% (327 usable replies). Pharmacist involvement in DUE program activities was found to be very high, with two thirds of respondents indicating they participated in all five ASHP-recommended activities. Pharmacists rated the effectiveness of current DUE programs as moderate, while the importance of pharmacist participation was perceived to be very high. Pharmacists were members of 97.9% of the respondents' DUE committees, but only 65.5% of the pharmacist members held voting privileges. Pharmacists reported devoting an average of 11.27 hours weekly to DUE-related tasks. Reasons used to select drugs for DUEs, interventions employed, uses of DUE results, and methods of evaluating the effectiveness of DUE programs all varied widely. In short- term-care general hospitals with 100 or more beds, pharmacists assigned to DUE activities were highly involved in DUE committees and programs. The effectiveness of these activities needs to be assessed in more detail.

KW - Administration

KW - American Society of Hospital Pharmacists

KW - Committees

KW - Data collection

KW - Drug use

KW - Guidelines

KW - Hospitals

KW - Pharmacists, hospital

KW - Pharmacy, institutional, hospital

UR - http://www.scopus.com/inward/record.url?scp=0027198737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027198737&partnerID=8YFLogxK

M3 - Article

C2 - 8506873

AN - SCOPUS:0027198737

VL - 50

SP - 940

EP - 944

JO - American Journal of Health-System Pharmacy

JF - American Journal of Health-System Pharmacy

SN - 1079-2082

IS - 5

ER -